Enhancing Stent Effectiveness with Nanofeatures
By: Nicole Bassous, John P. Cooke and Thomas J. Webster
References
- Fischman D , Leon M , Baim D , A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994 Aug 25; 331( 8): 496– 501.
- Serruys PW , de Jaegere P , Kiemeneij F , A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25; 331( 8): 489– 95.
- Nageh T Meier B. Treatment of in-stent restenosis. Int J Cardiol. 2005 Oct 10; 104( 3): 245– 50.
- Serruys P Gershlick A. Handbook of drug-eluting stents. London, England: Taylor & Francis Ltd; 2005. 356 p.
- Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A. 2003 Feb 4; 100( 3): 768– 70.
- McFadden EP , Stabile E , Regar E , Cheneau E , Late thrombosis in drug-eluting coronary stents after discontinuation of anti-platelet therapy. Lancet. 2004 Oct 23–29; 364( 9444): 1519– 21.
- Virmani R , Guagliumi G , Farb A , Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004 Feb 17; 109( 6): 701– 5.
- Joner M , Finn A , Farb A , Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006 Jul 4; 48( 1): 193– 202.
- Ong AT , McFadden EP , Regar E , de Jaegere PP , van Domburg RT , Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005 Jun 21; 45( 12): 2088– 92.
- Iakovou I , Schmidt T , Bonizzoni E , Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005 May 4; 293( 17): 2126– 30.
- Kuchulakanti P , Chu W , Torguson R , Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006 Feb 28; 113( 8): 1108– 13.
- Spertus J , Kettelkamp R , Vance C , Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006 Jun 20; 113( 24): 2803– 9.
- Cooke JP Ghebremariam YT. Dietary nitrate, nitric oxide, and restenosis. J Clin Invest. 2011 Apr; 121( 4): 1258– 60.
- Ma X , Wu T , Robich MP. Drug-eluting stent coatings. J Interv Cardiol. 2012; 4( 1): 73– 83.
- Protopopov AV , Kochkina TA , Konstantinov EP , Investigation of application of PHA coating to enhance biocompatibility of vascular stents. Dokl Biol Sci. 2005 Mar–Apr; 401: 85– 7.
- Kondyurin AV , Romanova V , Begishev V , Kondyurina I , Guenzel R , Maitz M. Crosslinked polyurethane coating on vascular stents for enhanced X-ray contrast. J Bioact Compat Pol. 2005; 20( 1): 77– 93.
- Choudhary S , Haberstroh K , Webster T. Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng. 2007 Jul; 13( 7): 1421– 30.
- Iakovou I , Schmidt T , Bonizzoni E , Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005 May 4; 293( 17): 2126– 30.
- Lim IA. Biocompatibility of stent materials. MIT Undergraduate Research Journal. 2004; 11( 1): 33– 7.
- Hara H , Nakamura M , Palmaz JC , Schwartz RS. Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliv Rev. 2006 Jun 3; 58( 3): 377– 86.
- Kereiakes DJ , Cox DA , Hermiller JB , et al; Guidant Multi-Link Vision Stent Registry Investigators. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol. 2003 Aug 15; 92( 4): 463– 6.
- Lu J. Nano-fabrication and characterization of novel titanium surfaces for vascular stent application [Thesis]. [Providence, RI]: Brown University; 2010. 295 p.
- Di Mario C , Marsico F , Adamian M , Karvouni E , Albiero R , Colombo A. New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima? Heart. 2000 Nov; 84( 5): 471– 5.
- vom Dahl J , Dietz U , Haager PK , Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation. 2002 Feb 5; 105( 5): 583– 8.
- Michaels AD Chatterjee K. Cardiology patient pages. Angioplasty versus bypass surgery for coronary artery disease. Circulation. 2002 Dec 3; 106( 23): e187– 90.
- Wessely R , Hausleiter J , Michaelis C , Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol. 2005 Apr; 25( 4): 748– 53.
- Hausleiter J , Kastrati A , Wessely R , Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating. Eur Heart J. 2005 Aug; 26( 15): 1475– 81.
- Moore P , Barlis P , Spiro J , A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. JACC Cardiovasc Interv. 2009 May; 2( 5): 437– 44.
-
Abizaid
A
,
Costa
JR
Jr. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv. 2010 Aug; 3( 4): 384– 93. - Tada N , Virmani R , Grant G , Polymer-free biolimus A9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. Circ Cardiovasc Interv. 2010 Apr; 3( 2): 174– 83.
- Cre8™ Technical Information. Retrieved from http://www.alvi-medica.com/cre8-technical-information/.
- Rajtar A , Kaluza GL , Yang Q , Hydroxyapatite-coated cardiovascular stents. EuroIntervention. 2006 May; 2( 1): 113– 5.
- Garg S , Bourantas C , Serruys PW. New concepts in the design of drug-eluting coronary stents. Nat Rev Cardiol. 2013 May; 10( 5): 248– 60.
- Wieneke H , Dirsch O , Sawitowski T , Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheter Cardiovasc Interv. 2003 Nov; 60( 3): 399– 407.
- Kollum M , Farb A , Schreiber R Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Catheter Cardiovasc Interv. 2005 Jan; 64( 1): 85– 90.
- Khang D , Lu J , Yao C , Haberstroh KM , Webster TJ. The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials. 2008 Mar; 29( 8): 970– 83.
- Nakano K , Egashira K , Masuda S , Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc Interv. 2009 Apr; 2( 4): 277– 83.
- Polyak B , Fishbein I , Chorny M , High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci U S A. 2008 Jan 15; 105( 2): 698– 703.
- Lai ES , Huang NF , Cooke JP , Fuller GG. Aligned nanofibrillar collagen regulates endothelial organization and migration. Regen Med. 2012 Sep; 7( 5): 649– 61.
- Huang NF , Okogbaa J , Lee JC , The modulation of endothelial cell morphology, function, and survival using anisotropic nano-fibrillar collagen scaffolds. Biomaterials. 2013 May; 34( 16): 4038– 47.
- Huang NF , Lai ES , Ribeiro AJ , Spatial patterning of endothelium modulates cell morphology, adhesiveness and transcriptional signature. Biomaterials. 2013 Apr; 34( 12): 2928– 37.
- Black J Hastings G. Handbook of biomaterial properties. London, England: Chapman & Hall; 1998. 589 p.
- Park H , Cannizzaro C , Vunjak-Novakovic G , Langer R , Vacanti C , Farokhzad O. Nanofabrication and microfabrication of functional materials for tissue engineering. Tissue Eng. 2007 Aug; 13( 8): 1867– 77.
- Park TH Shuler ML. Integration of cell culture and microfabrication technology. Biotechnol Prog. 2003 Mar–Apr; 19( 2): 243– 53.
- Chehroudi B , McDonnell D , Brunette DM. The effects of micro-machined surfaces on formation of bonelike tissue on subcutaneous implants as assessed by radiography and computer image processing. J Biomed Mater Res. 1997 Mar 5; 34( 3): 279– 90.
- Sarkar S , Dadhania M , Rourke P , Desai T , Wong J. Vascular tissue engineering: microtextured scaffold templates to control organization of vascular smooth muscle cells and extracellular matrix. Acta Biomater. 2005 Jan; 1( 1): 93– 100.
- Shin M , Matsuda K , Ishii O , Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices. 2004 Dec; 6( 4): 269– 78.
- Windecker S , Mayer I , De Pasquale G , et al; Working Group on Novel Surface Coating of Biomedical Devices (SCOL). Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation. 2001 Aug 21; 104( 8): 928– 33.
- Sternberg K , Grabow N , Petersen S , Advances in coronary stent technology--active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility. Curr Pharm Biotechnol. 2013; 14( 1): 76– 90.
- Colombo A Karvouni E. Biodegradable stents: “fulfilling the mission and stepping away”. Circulation. 2000 Jul 25; 102( 4): 371– 3.
- Grabow N , Bünger CM , Schultze C , A biodegradable slotted tube stent based on poly(L-lactide) and poly(4-hydroxy-butyrate) for rapid balloon-expansion. Ann Biomed Eng. 2007 Dec; 35( 12): 2031– 8.
- Zartner P , Buettner M , Singer H , Sigler M. First biodegradable metal stent in a child with congenital heart disease: evaluation of macro and histopathology. Catheter Cardiovasc Interv. 2007 Feb 15; 69( 3): 443– 6.
- Uurto I , Juuti H , Parkkinen J. Biodegradable self-expanding poly-L/D-lactic acid vascular stent: a pilot study in canine and porcine iliac arteries. J Endovasc Ther. 2004 Dec; 11( 6): 712– 8.
- Venkatraman SS , Tan LP , Joso JF , Boey YC , Wang X. Biodegradable stents with elastic memory. Biomaterials. 2006 Mar; 27( 8): 1573– 8.
- Wong YS , Xiong Y , Venkatraman SS , Boey FY. Shape memory in un-cross-linked biodegradable polymers. J Biomater Sci Polym Ed. 2008; 19( 2): 175– 91.
- Bünger CM , Grabow N , Kröger C , Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks. J Endovasc Ther. 2006 Oct; 13( 5): 630– 9.
- Venkatraman S , Poh TL , Vinalia T , Mak KH , Boey F. Collapse pressures of biodegradable stents. Biomaterials. 2003 May; 24( 12): 2105– 11.
- Zilberman M , Nelson KD , Eberhart RC. Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents. J Biomed Mater Res B Appl Biomater. 2005 Aug; 74( 2): 792– 9.
- Welch TR , Eberhart RC , Chuong CJ. The influence of thermal treatment on the mechanical characteristics of a PLLA coiled stent. J Biomed Mater Res B Appl Biomater. 2009 Jul; 90( 1): 302– 11.
- Ormiston JA1 , Webster MW , Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv. 2007 Jan; 69( 1): 128– 31.
- Serruys PW , Ormiston JA , Onuma Y , A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009 Mar 14; 373( 9667): 897– 910.
- Bruining N , de Winter S , Roelandt JR , Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study. JACC Cardiovasc Interv. 2010 Apr; 3( 4): 449– 56.
- Peuster M , Wohlsein P , Brügmann M , A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6–18 months after implantation into New Zealand white rabbits. Heart. 2001 Nov; 86( 5): 563– 9.
- Peuster M , Hesse C , Schloo T , Fink C , Beerbaum P , von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials. 2006 Oct; 27( 28): 4955– 62.
- Di Mario C , Griffiths H , Goktekin O , Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol. 2004 Dec; 17( 6): 391– 5.
- Erbel R , Di Mario C , Bartunek J , PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet. 2007 Jun 2; 369( 9576): 1869– 75.
- Waksman R , Erbel R , Di Mario C , et al; PROGRESS-AMS (Clinical Performance Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators. Early- and long-term in-travascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. JACC Cardiovasc Interv. 2009 Apr; 2( 4): 312– 20.
- Santos A , Aw MS , Bariana M , Kumeria T , Wang Y , Losic D. Drug-releasing implants: current progress, challenges, and perspectives. J Mater Chem. 2014; 2: 6157– 82.
DOI: https://doi.org/10.14797/mdcj-12-3-163 | Journal eISSN: 1947-6108
Language: English
Page range: 163 - 168
Published on: Jul 1, 2016
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2016 Nicole Bassous, John P. Cooke, Thomas J. Webster, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.